Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells

The anti-inflammatory role of regulatory B cells (Breg cells) has been associated with IL-35 based on studies of experimental autoimmune uveitis and encephalitis. The role of Breg cells and IL-35<sup>+</sup> Breg cells for type 1 diabetes (T1D) remains to be investigated. We studied PBMC...

Full description

Bibliographic Details
Main Authors: Zhengkang Luo, Sara Lundin, Mariela Mejia-Cordova, Imane Hassani, Martin Blixt, Daisy Hjelmqvist, Joey Lau, Daniel Espes, Per-Ola Carlsson, Stellan Sandler, Kailash Singh
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/23/12988
_version_ 1797507703071834112
author Zhengkang Luo
Sara Lundin
Mariela Mejia-Cordova
Imane Hassani
Martin Blixt
Daisy Hjelmqvist
Joey Lau
Daniel Espes
Per-Ola Carlsson
Stellan Sandler
Kailash Singh
author_facet Zhengkang Luo
Sara Lundin
Mariela Mejia-Cordova
Imane Hassani
Martin Blixt
Daisy Hjelmqvist
Joey Lau
Daniel Espes
Per-Ola Carlsson
Stellan Sandler
Kailash Singh
author_sort Zhengkang Luo
collection DOAJ
description The anti-inflammatory role of regulatory B cells (Breg cells) has been associated with IL-35 based on studies of experimental autoimmune uveitis and encephalitis. The role of Breg cells and IL-35<sup>+</sup> Breg cells for type 1 diabetes (T1D) remains to be investigated. We studied PBMCs from T1D subjects and healthy controls (HC) and found lowered proportions of Breg cells and IL-35<sup>+</sup> Breg cells in T1D. To elucidate the role of Breg cells, the lymphoid organs of two mouse models of T1D were examined. Lower proportions of Breg cells and IL-35<sup>+</sup> Breg cells were found in the animal models of T1D compared with control mice. In addition, the systemic administration of recombinant mouse IL-35 prevented hyperglycemia after multiple low dose streptozotocin (MLDSTZ) injections and increased the proportions of Breg cells and IL-35<sup>+</sup> Breg cells. A higher proportion of IFN-γ<sup>+</sup> cells among Breg cells were found in the PBMCs of the T1D subjects. In the MLDSTZ mice, IL-35 administration decreased the proportions of IFN-γ<sup>+</sup> cells among the Breg cells. Our data illustrate that Breg cells may play an important role in the development of T1D and that IL-35 treatment prevents the development of hyperglycemia by maintaining the phenotype of the Breg cells under an experimental T1D condition.
first_indexed 2024-03-10T04:52:12Z
format Article
id doaj.art-54e51940bdee4665960904dd5d9ea963
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T04:52:12Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-54e51940bdee4665960904dd5d9ea9632023-11-23T02:31:27ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-11-0122231298810.3390/ijms222312988Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B CellsZhengkang Luo0Sara Lundin1Mariela Mejia-Cordova2Imane Hassani3Martin Blixt4Daisy Hjelmqvist5Joey Lau6Daniel Espes7Per-Ola Carlsson8Stellan Sandler9Kailash Singh10Department of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenScience for Life Laboratory, Department of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenDepartment of Medical Cell Biology, Uppsala University, 75123 Uppsala, SwedenThe anti-inflammatory role of regulatory B cells (Breg cells) has been associated with IL-35 based on studies of experimental autoimmune uveitis and encephalitis. The role of Breg cells and IL-35<sup>+</sup> Breg cells for type 1 diabetes (T1D) remains to be investigated. We studied PBMCs from T1D subjects and healthy controls (HC) and found lowered proportions of Breg cells and IL-35<sup>+</sup> Breg cells in T1D. To elucidate the role of Breg cells, the lymphoid organs of two mouse models of T1D were examined. Lower proportions of Breg cells and IL-35<sup>+</sup> Breg cells were found in the animal models of T1D compared with control mice. In addition, the systemic administration of recombinant mouse IL-35 prevented hyperglycemia after multiple low dose streptozotocin (MLDSTZ) injections and increased the proportions of Breg cells and IL-35<sup>+</sup> Breg cells. A higher proportion of IFN-γ<sup>+</sup> cells among Breg cells were found in the PBMCs of the T1D subjects. In the MLDSTZ mice, IL-35 administration decreased the proportions of IFN-γ<sup>+</sup> cells among the Breg cells. Our data illustrate that Breg cells may play an important role in the development of T1D and that IL-35 treatment prevents the development of hyperglycemia by maintaining the phenotype of the Breg cells under an experimental T1D condition.https://www.mdpi.com/1422-0067/22/23/12988breg cellsIL-35type 1 diabetes
spellingShingle Zhengkang Luo
Sara Lundin
Mariela Mejia-Cordova
Imane Hassani
Martin Blixt
Daisy Hjelmqvist
Joey Lau
Daniel Espes
Per-Ola Carlsson
Stellan Sandler
Kailash Singh
Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
International Journal of Molecular Sciences
breg cells
IL-35
type 1 diabetes
title Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
title_full Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
title_fullStr Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
title_full_unstemmed Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
title_short Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
title_sort interleukin 35 prevents development of autoimmune diabetes possibly by maintaining the phenotype of regulatory b cells
topic breg cells
IL-35
type 1 diabetes
url https://www.mdpi.com/1422-0067/22/23/12988
work_keys_str_mv AT zhengkangluo interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT saralundin interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT marielamejiacordova interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT imanehassani interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT martinblixt interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT daisyhjelmqvist interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT joeylau interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT danielespes interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT perolacarlsson interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT stellansandler interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells
AT kailashsingh interleukin35preventsdevelopmentofautoimmunediabetespossiblybymaintainingthephenotypeofregulatorybcells